Alzheimer’s Disease: Significant Benefit from the Yeast-Based Models

Alzheimer’s Disease: Significant Benefit from the Yeast-Based Models

Alzheimer’s disease (AD) is an age-related, multifaceted neurological disorder associated with accumulation of aggregated proteins (amyloid Aβ and hyperphosphorylated tau), loss of synapses and neurons, and alterations in microglia. AD was recognized by the World Health Organization as a global publ...

Full description

Bibliographic Details
Main Authors:	Khoren K. Epremyan, Dmitry V. Mamaev, Renata A. Zvyagilskaya
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	International Journal of Molecular Sciences
Subjects:	Alzheimer’s disease yeast models amyloid-β peptide phosphorylated tau protein mitochondrial dysfunction mitotherapy
Online Access:	https://www.mdpi.com/1422-0067/24/12/9791

Similar Items

Dietary glucosinolates derived isothiocyanates: chemical properties, metabolism and their potential in prevention of Alzheimer’s disease
by: Farhana Khan, et al.
Published: (2023-07-01)

Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer’s Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis
by: Abdalla Bowirrat
Published: (2022-11-01)

Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer’s Disease
by: Yi-Hsuan Wu, et al.
Published: (2023-09-01)

Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
by: Syed Haris Omar, et al.
Published: (2020-07-01)

The peptidyl prolyl cis/trans isomerase Pin1/Ess1 inhibits phosphorylation and toxicity of tau in a yeast model for Alzheimer’s disease
by: Ann De Vos, et al.
Published: (2015-04-01)

Cerebrospinal and Blood Biomarkers in Alzheimer’s Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?
by: Giulia Bivona, et al.
Published: (2023-11-01)

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

Alzheimer’s disease and anesthesia
by: Marie-Amélie ePapon, et al.
Published: (2011-01-01)

In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged Neurotoxicity
by: Samir Kumar-Singh, et al.
Published: (2002-11-01)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
by: Jean-Marie eSontag, et al.
Published: (2014-03-01)

Effects of early tooth loss on chronic stress and progression of neuropathogenesis of Alzheimer’s disease in adult Alzheimer’s model AppNL-G-F mice
by: Suzuko Ochi, et al.
Published: (2024-02-01)

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
by: Anushka Chakravorty, et al.
Published: (2019-11-01)

Pathophysiology of Alzheimer’s Disease
by: Mohammad Amani
Published: (2017-01-01)

Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study
by: James A. Hendrix, et al.
Published: (2021-04-01)

Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice
by: Ailing Fu, et al.
Published: (2017-05-01)

Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease
by: Somayra S. A. Mamsa, et al.
Published: (2021-10-01)

Tau: The Center of a Signaling Nexus in Alzheimer’s Disease
by: Shahzad eKhan, et al.
Published: (2016-02-01)

Research Progress of Pyroptosis in Alzheimer’s Disease
by: Weiyue Xue, et al.
Published: (2022-06-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
by: Yinyi Xiong, et al.
Published: (2021-09-01)

Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
by: Kaden L. Nystuen, et al.
Published: (2024-01-01)

Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer’s Disease
by: Débora A. Moreira, et al.
Published: (2023-03-01)

Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease
by: Susana López-Ortiz, et al.
Published: (2021-03-01)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
by: Tiwari S, et al.
Published: (2019-07-01)

The role of oxidative stress in the development of Alzheimer's disease
by: V. N. Nikolenko, et al.
Published: (2022-08-01)

Altered Mitochondrial Morphology and Bioenergetics in a New Yeast Model Expressing Aβ42
by: Khoren K. Epremyan, et al.
Published: (2023-01-01)

Chasing the effects of Pre-analytical Confounders - a Multicentre Study on CSF-AD biomarkers
by: Maria Joao Leitao, et al.
Published: (2015-07-01)

Peptidyl-Prolyl Cis/Trans Isomerase Pin1 and Alzheimer’s Disease
by: Long Wang, et al.
Published: (2020-05-01)

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
by: Joana R. Guedes, et al.
Published: (2018-08-01)

The Wnt/β-catenin signaling pathway affects the distribution of cytoskeletal proteins in Aβ treated PC12 cells
by: Zhifeng Tian, Xiaoling Zhang, Zhijun Zhao, Fuhua Zhang, Tongxing Deng
Published: (2019-09-01)

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels
by: Melissa E. Murray, et al.
Published: (2022-12-01)

Alzheimer’s disease as an inflammatory disease
by: Bolós Marta, et al.
Published: (2017-02-01)

Dysfunction of Mitochondria in Alzheimer’s Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells
by: Anna Atlante, et al.
Published: (2022-07-01)

High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer’s Disease Patients but Not in Non-Alzheimer’s Disease Dementia
by: Giulia Bivona, et al.
Published: (2022-09-01)

A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease
by: Rubayat Islam Khan, et al.
Published: (2018-08-01)

History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer’s disease
by: Mohd Sajad, et al.
Published: (2022-06-01)

New Therapeutic Targets in Alzheimer's Disease
by: Horia Coman, et al.
Published: (2017-03-01)

PICALM rs3851179 Variants Modulate Left Postcentral Cortex Thickness, CSF Amyloid β42, and Phosphorylated Tau in the Elderly
by: Zhiwei Wu, et al.
Published: (2022-12-01)

APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
by: Takahito Maki, et al.
Published: (2022-10-01)

Calcium Dyshomeostasis in Alzheimer’s Disease Pathogenesis
by: Roberta Cascella, et al.
Published: (2021-05-01)